CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: pevonedistat
Accession: CHEBI:145535
browse the term
Definition: A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine which is substituted by a (1S)-2,3-dihydro-1H-inden-1-ylnitrilo group at position 4 and by a (1S,3S,4S)-3-hydroxy-4-[(sulfamoyloxy)methyl]cyclopentyl group at position 7. It is a potent and selective NEDD8-activating enzyme inhibitor with an IC50 of 4.7 nM, and currently under clinical investigation for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes.
Synonyms: exact_synonym: [(1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate
related_synonym: Formula=C21H25N5O4S; InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1; InChIKey=MPUQHZXIXSTTDU-QXGSTGNESA-N; MLN 4924; MLN4924; SMILES=C1=CC2=C(C=C1)[C@H](CC2)NC3=C4C(=NC=N3)N(C=C4)[C@@H]5C[C@H]([C@H](C5)O)COS(N)(=O)=O; [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxy-cyclopentyl]methyl sulfamate; pevonedistatum
xref: CAS:905579-51-3; DrugBank:DB11759; KEGG:D10413; LINCS:LSM-6263
xref_mesh: MESH:C539933
xref: PDBeChem:B39; PMID:19360080; PMID:20129059; PMID:25733005; PMID:26292710; PMID:26561559; PMID:27551465; PMID:27783255; PMID:27901050; PMID:28578874; PMID:28717191; PMID:28838998; PMID:29348128; PMID:29667067; PMID:30020196; PMID:30341788; PMID:30545630; PMID:30556867; PMID:30845347; PMID:30850948; PMID:31002342; PMID:31355467; PMID:31528694; PMID:31665821; Wikipedia:Pevonedistat
G
Bbc3
Bcl-2 binding component 3
affects expression
ISO
pevonedistat affects the expression of BBC3 mRNA
CTD
PMID:24634471
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
affects expression
ISO
pevonedistat affects the expression of BCL2 mRNA
CTD
PMID:24634471
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
affects expression
ISO
pevonedistat affects the expression of BCL2L1 mRNA
CTD
PMID:24634471
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bcl2l11
Bcl2-like 11
affects expression
ISO
pevonedistat affects the expression of BCL2L11 mRNA; pevonedistat affects the expression of BCL2L11 protein
CTD
PMID:24634471
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:115,366,646...115,404,068
G
Casp3
caspase 3
multiple interactions
ISO
pevonedistat inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; pevonedistat inhibits the reaction [Cisplatin results in increased expression of CASP3 mRNA]; pevonedistat results in increased cleavage of and results in increased activity of CASP3 protein; Tretinoin promotes the reaction [pevonedistat results in increased cleavage of and results in increased activity of CASP3 protein]
CTD
PMID:22110742 PMID:34476871
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Ccl17
C-C motif chemokine ligand 17
affects expression
ISO
pevonedistat affects the expression of CCL17 mRNA
CTD
PMID:24634471
NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,202,128...10,203,819
G
Ccl22
C-C motif chemokine ligand 22
affects expression
ISO
pevonedistat affects the expression of CCL22 mRNA
CTD
PMID:24634471
NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,257,601...10,264,400
G
Ccl5
C-C motif chemokine ligand 5
affects expression
ISO
pevonedistat affects the expression of CCL5 mRNA
CTD
PMID:24634471
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Ccnd1
cyclin D1
affects expression
ISO
pevonedistat affects the expression of CCND1 mRNA
CTD
PMID:24634471
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
affects expression
ISO
pevonedistat affects the expression of CCND2 mRNA
CTD
PMID:24634471
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:159,962,363...159,989,495
G
Cd40
CD40 molecule
affects expression
ISO
pevonedistat affects the expression of CD40 mRNA
CTD
PMID:24634471
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd74
CD74 molecule
affects expression
ISO
pevonedistat affects the expression of CD74 mRNA
CTD
PMID:24634471
NCBI chr18:56,527,071...56,536,406
Ensembl chr18:54,256,778...54,266,003
G
Cdt1
chromatin licensing and DNA replication factor 1
increases abundance
ISO
pevonedistat results in increased abundance of CDT1 protein
CTD
PMID:22110742
NCBI chr19:67,529,249...67,534,195
Ensembl chr19:50,620,713...50,625,659
G
Cflar
CASP8 and FADD-like apoptosis regulator
affects expression
ISO
pevonedistat affects the expression of CFLAR mRNA
CTD
PMID:24634471
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034
G
Ctnnb1
catenin beta 1
increases abundance multiple interactions
ISO
pevonedistat results in increased abundance of CTNNB1 protein pevonedistat inhibits the reaction [Cisplatin results in decreased expression of CTNNB1 mRNA]
CTD
PMID:22110742 PMID:34476871
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Cul1
cullin 1
decreases metabolic processing
ISO
pevonedistat results in decreased metabolism of CUL1 protein
CTD
PMID:22110742
NCBI chr 4:77,551,781...77,634,210
Ensembl chr 4:76,551,983...76,627,980
G
Cxcl9
C-X-C motif chemokine ligand 9
affects expression
ISO
pevonedistat affects the expression of CXCL9 mRNA
CTD
PMID:24634471
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:15,722,908...15,728,435
G
Cxcr3
C-X-C motif chemokine receptor 3
affects expression
ISO
pevonedistat affects the expression of CXCR3 mRNA
CTD
PMID:24634471
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:66,844,318...66,846,969
G
Cxcr5
C-X-C motif chemokine receptor 5
affects expression
ISO
pevonedistat affects the expression of CXCR5 mRNA
CTD
PMID:24634471
NCBI chr 8:53,738,878...53,756,813
Ensembl chr 8:44,843,413...44,857,893
G
Epas1
endothelial PAS domain protein 1
multiple interactions
ISO
[Formaldehyde co-treated with pevonedistat co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] affects the folding of EPAS1 protein
CTD
PMID:35504338
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:7,790,647...7,871,228
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
affects expression
ISO
pevonedistat affects the expression of GADD45B mRNA
CTD
PMID:24634471
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:8,778,007...8,780,046
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
[Formaldehyde co-treated with pevonedistat co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] affects the folding of HIF1A protein
CTD
PMID:35504338
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hsf1
heat shock transcription factor 1
increases activity
ISO
pevonedistat results in increased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:108,196,056...108,223,011
G
Il1b
interleukin 1 beta
multiple interactions
ISO
pevonedistat inhibits the reaction [Cisplatin results in increased expression of IL1B protein]
CTD
PMID:34476871
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
pevonedistat inhibits the reaction [Cisplatin results in increased expression of IL6 protein]
CTD
PMID:34476871
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases abundance multiple interactions
ISO
pevonedistat results in increased abundance of JUN protein Tretinoin promotes the reaction [pevonedistat results in increased abundance of JUN protein]
CTD
PMID:22110742
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Maf1
MAF1 homolog, negative regulator of RNA polymerase III
increases expression
ISO
pevonedistat results in increased expression of MAF1 protein
CTD
PMID:31645432
NCBI chr 7:109,955,876...109,958,909
Ensembl chr 7:108,075,189...108,078,249
G
Mir155hg
Mir155 host gene
affects expression
ISO
pevonedistat affects the expression of MIR155HG mRNA
CTD
PMID:24634471
NCBI chr11:37,259,928...37,262,157
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
pevonedistat results in increased expression of MYC protein
CTD
PMID:25897075
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
pevonedistat inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 mRNA]
CTD
PMID:34476871
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
affects activity
ISO
pevonedistat affects the activity of NFKB1 protein
CTD
PMID:24634471
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
increases phosphorylation
ISO
pevonedistat results in increased phosphorylation of NFKBIA protein
CTD
PMID:22110742 PMID:24634471
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
pevonedistat results in increased cleavage of PARP1 protein pevonedistat results in increased cleavage of and results in increased activity of PARP1 protein; Tretinoin promotes the reaction [pevonedistat results in increased cleavage of and results in increased activity of PARP1 protein]
CTD
PMID:22110742 PMID:24634471
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases abundance multiple interactions affects expression
ISO
pevonedistat results in increased abundance of PMAIP1 protein Tretinoin promotes the reaction [pevonedistat results in increased abundance of PMAIP1 protein] pevonedistat affects the expression of PMAIP1 mRNA
CTD
PMID:22110742 PMID:24634471
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:59,986,017...59,992,429
G
Rela
RELA proto-oncogene, NF-kB subunit
affects activity
ISO
pevonedistat affects the activity of RELA protein
CTD
PMID:24634471
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rictor
RPTOR independent companion of MTOR, complex 2
increases expression
ISO
pevonedistat results in increased expression of RICTOR protein
CTD
PMID:25897075
NCBI chr 2:57,539,279...57,631,291
Ensembl chr 2:55,811,322...55,901,426
G
Rptor
regulatory associated protein of MTOR, complex 1
increases expression
ISO
pevonedistat results in increased expression of RPTOR protein
CTD
PMID:25897075
NCBI chr10:105,376,943...105,675,416
Ensembl chr10:104,878,487...105,176,983
G
Sall4
spalt-like transcription factor 4
multiple interactions
ISO
pevonedistat inhibits the reaction [Thalidomide results in increased degradation of and results in decreased expression of SALL4 protein]
CTD
PMID:30067223
NCBI chr 3:177,891,705...177,909,743
Ensembl chr 3:157,474,642...157,490,822
G
Stat5a
signal transducer and activator of transcription 5A
affects expression
ISO
pevonedistat affects the expression of STAT5A mRNA
CTD
PMID:24634471
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:85,785,537...85,809,866
G
Tnf
tumor necrosis factor
multiple interactions
ISO
pevonedistat inhibits the reaction [Cisplatin results in increased expression of TNF protein]
CTD
PMID:34476871
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
multiple interactions
ISO
pevonedistat inhibits the reaction [Cisplatin results in decreased expression of TNFAIP3 mRNA]
CTD
PMID:34476871
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:13,709,206...13,725,282
G
Uba3
ubiquitin-like modifier activating enzyme 3
decreases activity
ISO
pevonedistat results in decreased activity of UBA3 protein
CTD
PMID:22110742
NCBI chr 4:129,789,526...129,810,707
Ensembl chr 4:129,789,204...129,810,606
G
Wee1
WEE1 G2 checkpoint kinase
increases abundance
ISO
pevonedistat results in increased abundance of WEE1 protein
CTD
PMID:22110742
NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:164,174,779...164,197,688
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all